Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005829 | cytosol | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: E9ACT8
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 11 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016311 | dephosphorylation | 5 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0036211 | protein modification process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 11 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 2 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 11 |
GO:0016791 | phosphatase activity | 5 | 11 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.580 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.780 |
CLV_NRD_NRD_1 | 286 | 288 | PF00675 | 0.410 |
CLV_NRD_NRD_1 | 334 | 336 | PF00675 | 0.696 |
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.486 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.716 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 334 | 336 | PF00082 | 0.718 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.464 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.781 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.306 |
CLV_PCSK_PC7_1 | 204 | 210 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.593 |
DOC_CKS1_1 | 219 | 224 | PF01111 | 0.306 |
DOC_CKS1_1 | 85 | 90 | PF01111 | 0.425 |
DOC_CYCLIN_RxL_1 | 137 | 149 | PF00134 | 0.512 |
DOC_CYCLIN_RxL_1 | 26 | 35 | PF00134 | 0.455 |
DOC_CYCLIN_RxL_1 | 284 | 294 | PF00134 | 0.357 |
DOC_MAPK_gen_1 | 137 | 145 | PF00069 | 0.426 |
DOC_PP1_RVXF_1 | 27 | 34 | PF00149 | 0.455 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.684 |
DOC_USP7_MATH_1 | 338 | 342 | PF00917 | 0.565 |
DOC_WW_Pin1_4 | 218 | 223 | PF00397 | 0.488 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.441 |
DOC_WW_Pin1_4 | 305 | 310 | PF00397 | 0.279 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.793 |
DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.619 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.555 |
LIG_14-3-3_CanoR_1 | 173 | 179 | PF00244 | 0.601 |
LIG_14-3-3_CanoR_1 | 209 | 219 | PF00244 | 0.298 |
LIG_14-3-3_CanoR_1 | 290 | 300 | PF00244 | 0.340 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.413 |
LIG_14-3-3_CterR_2 | 350 | 352 | PF00244 | 0.501 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.454 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.694 |
LIG_FHA_1 | 85 | 91 | PF00498 | 0.591 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.417 |
LIG_FHA_2 | 200 | 206 | PF00498 | 0.234 |
LIG_LIR_Gen_1 | 228 | 236 | PF02991 | 0.281 |
LIG_LIR_Gen_1 | 251 | 260 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 228 | 234 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 251 | 255 | PF02991 | 0.325 |
LIG_Pex14_1 | 194 | 198 | PF04695 | 0.355 |
LIG_Pex14_2 | 225 | 229 | PF04695 | 0.279 |
LIG_Pex14_2 | 248 | 252 | PF04695 | 0.357 |
LIG_PTAP_UEV_1 | 60 | 65 | PF05743 | 0.630 |
LIG_REV1ctd_RIR_1 | 25 | 33 | PF16727 | 0.458 |
LIG_RPA_C_Fungi | 111 | 123 | PF08784 | 0.487 |
LIG_SH2_PTP2 | 231 | 234 | PF00017 | 0.210 |
LIG_SH2_SRC | 318 | 321 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.255 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.279 |
LIG_SH3_3 | 220 | 226 | PF00018 | 0.310 |
LIG_SH3_3 | 58 | 64 | PF00018 | 0.805 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.509 |
LIG_TRAF2_1 | 94 | 97 | PF00917 | 0.493 |
LIG_TRAF2_2 | 9 | 14 | PF00917 | 0.537 |
LIG_UBA3_1 | 122 | 129 | PF00899 | 0.384 |
LIG_WRC_WIRS_1 | 175 | 180 | PF05994 | 0.593 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.666 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.464 |
MOD_CK1_1 | 308 | 314 | PF00069 | 0.350 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.718 |
MOD_CK2_1 | 115 | 121 | PF00069 | 0.468 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.602 |
MOD_CK2_1 | 199 | 205 | PF00069 | 0.329 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.704 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.627 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.410 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.471 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.442 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.398 |
MOD_GlcNHglycan | 340 | 343 | PF01048 | 0.628 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.761 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.694 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.302 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.627 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.795 |
MOD_N-GLC_1 | 153 | 158 | PF02516 | 0.583 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.427 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.621 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.691 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.492 |
MOD_PIKK_1 | 70 | 76 | PF00454 | 0.693 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.732 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.483 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.720 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.392 |
MOD_ProDKin_1 | 218 | 224 | PF00069 | 0.488 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.441 |
MOD_ProDKin_1 | 305 | 311 | PF00069 | 0.279 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.792 |
MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.616 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.279 |
TRG_ER_diArg_1 | 349 | 351 | PF00400 | 0.577 |
TRG_Pf-PMV_PEXEL_1 | 335 | 340 | PF00026 | 0.572 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDK0 | Leptomonas seymouri | 44% | 100% |
A0A1X0NRN9 | Trypanosomatidae | 46% | 100% |
A0A3S7X0Z1 | Leishmania donovani | 93% | 100% |
A0A422N807 | Trypanosoma rangeli | 39% | 100% |
A4HFZ8 | Leishmania braziliensis | 72% | 99% |
A4I317 | Leishmania infantum | 94% | 100% |
C9ZJI6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AZC7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5BIV4 | Trypanosoma cruzi | 38% | 100% |